English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily Report | May 15, 2023

Perrigo VP: 'Today's vote reflects the strong data showing that Opill® can be used safely and effectively over the counter'

Patient Daily Report | May 13, 2023

ByHeart: 'No other company in the infant formula industry is accomplishing what ByHeart is achieving'

Patient Daily Report | May 12, 2023

'It may actually rejuvenate sick tissue, and that’s pretty exciting': Doctors study using radiation to treat irregular heartbeats'

Patient Daily Report | May 11, 2023

New Medical Device Offers Solution for Abnormal Uterine Bleeding

Sam Jackson | May 10, 2023

Scottsdale doctor on sinusitis: 'If quality of life is not optimized, it's our job as physicians to help patients navigate through those challenges'

Patient Daily Report | May 10, 2023

Medtronic receives approval for new automated insulin pump that offers insulin corrections in real time

Patient Daily | May 9, 2023

Lilly Provides $500,000 in Grants to Support Equitable Access to Education for Dreamers in Indiana

Patient Daily | May 9, 2023

Lilly Declares Second-Quarter 2023 Dividend

Trending

+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program

+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program

+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'

Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’

  • « First
  • «
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily